FDA lifts hold on Telik cancer drug trials

[Christine]

Silicon Valley / San Jose Business Journal

Telik Inc. said Monday a partial hold on clinical trials for its cancer drug was lifted by the U.S. Food and Drug Administration.

The Palo Alto-based biopharm (NASDAQ:TELK) said it was asked in June to temporarily halt trials for Telcyta, designed to treat ovarian and lung cancer.

The company said the FDA had some safety concerns over the drug.

Telik said that after a complete review of data, regulators permitted clinical development to resume on Telcyta.

[RandyW]

thanks!!!